Rocket Lab Corporation (RKLB) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript

Rocket Lab said Electron has been launched 88 times, including 21 launches last year and an expected upper-20s cadence this year, with factory capacity sized at 1 launch per week. Management also said the company has 3 launch pads and licensed capacity for roughly 140 launches per year, suggesting meaningful runway for scale, though additional factory footprint would be needed to double current throughput again.

Analysis

The key takeaway is that launch is no longer the binding constraint for RKLB; factory throughput is. That matters because it shifts the next leg of growth from a capital-light cadence expansion to a more capex- and execution-intensive manufacturing ramp, which usually compresses near-term margin visibility even as revenue momentum looks strong. In other words, the market may be underestimating how much of the launch upside is already “available” versus how much incremental value still sits in space systems and future Neutron optionality.

The second-order winner is the broader defense and smallsat supply chain: higher Electron cadence increases the installed base of missions that need follow-on components, avionics, and mission services, which should help recurring systems revenue outgrow launch over the next 12-24 months. The likely loser is any small-launch competitor that is still trying to compete on cadence without a vertically integrated manufacturing footprint; once a provider hits repeat launch tempo and can absorb fixed infrastructure across more missions, price competition becomes harder to sustain.

The main risk is that the market extrapolates launch cadence too linearly. If factory expansion takes longer than expected, RKLB can still grow launches but may not convert that into enough margin expansion to justify premium multiples, especially if launch mix shifts toward lower-margin contracted missions. The catalyst window is the next 2-3 quarters: evidence of production bottlenecks, hiring/capex ramps, or any delay in converting pad capacity into realized launches would be the first signal that the growth curve is flattening.

The contrarian view is that the best trade may not be the stock itself, but the volatility around execution milestones. With the business transitioning from capacity-constrained demand to manufacturing-constrained supply, outcomes should widen: upside if the company shows it can scale factory output without margin dilution, downside if capex and working capital outpace cadence gains. That makes the setup attractive for event-driven positioning rather than a passive long if the name is already priced for flawless execution.

Key Decisions for Investors

• Long RKLB into visible launch cadence updates over the next 1-2 quarters, but size modestly; the upside is driven by manufacturing scale evidence, while the downside is a valuation reset if factory expansion lags cadence growth.
• Buy RKLB call spreads 3-6 months out to express upside from a successful throughput ramp while limiting premium burn if execution stalls; best risk/reward if implied vol remains elevated but not extreme.
• Pair trade: long RKLB / short a smaller launch peer or space hardware pure-play with weaker vertical integration for 6-12 months; thesis is that scale and factory control should widen the moat as cadence rises.
• If RKLB rallies hard on launch-count headlines without corresponding commentary on margin or factory expansion, take profits into strength; the market may be front-running capacity that still needs capex to unlock.